Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
At last the UK is getting serious about reducing mother to child transmission
For five years we have known that administering
zidovudine to HIV infected women during pregnancy and in labour, and to
the neonate for the first 6 weeks of life, greatly reduces mother to
child transmission of HIV.1 This intervention,
together with delivery by caesarean section and avoiding breast
feeding, has reduced the risk of transmission from over 20% to well
under 5%.2 In the United States,
where antiretroviral therapy is widely used to reduce perinatal
transmission, the incidence of AIDS in infants, a sensitive indicator
of mother to child transmission, has fallen by 80%.3 In
the United Kingdom, although routine antenatal testing for HIV
infection has officially been recommended for high prevalence areas
since 1994, most maternal HIV infections remain
undetected.4 Thus the number of infants presenting with AIDS in the UK has not declined, as it has in other European countries, and in 1997 was higher than in France, Italy, or Spain. Yet these countries have adult HIV burdens four or more times greater than that
of the UK.5
In 1997 the unlinked anonymous programmes of HIV testing found evidence
of 265 births to HIV infected women, 195 in London, 14 in Scotland, and
56 elsewhere in the UK. Allowing for areas outside the programmes, this
amounts to an estimated 300 births to HIV infected women each year in
the UK By 31 December 2000 all health authorities should attain the
following targets:
By 31 December 2002 all health authorities should
achieve:
A fuller version of the targets appears on the
BMJ's website: www.bmj.com.
8 9
over 70% of whom would be unaware of their
infection.4 What underlies this
failure? Until recently, and despite the official guidelines, few
hospitals offered HIV testing as part of routine screening. Some
offered it in addition to routine tests; in others mothers would be
referred to a sexually transmitted disease clinic or not offered the
test at all.6 Furthermore, while one professional might
commend the test another would remain diffident.7
Consequently whether or not a woman was offered an HIV test, and how
she was offered it, depended on where she received her antenatal care and the attitude of individual health professionals. This is scarcely a
fair and acceptable situation considering that failure to offer the
test seems to be a much greater barrier to preventing mother to child
transmission than any reluctance of mothers to accept effective
interventions when indicated.
2 6 7
National antenatal HIV targets (England)
This August the government made a commitment to change this situation, setting a national objective of reducing the numbers of children acquiring HIV infection from their mothers by 80% by the end of 2002. The key policy change was to make the offer of an antenatal HIV test a routine and integral part of antenatal care across England. Wales will follow suit while decisions are awaited from Scotland and Northern Ireland.8 Targets for achieving this were outlined in an accompanying circular and expert group report (see box and fuller details on www.bmj.com).9
The National Screening Committee had already sought assurance that the universal offer of an HIV test met the cost effectiveness criteria applied to other screening programmes, and this was shown to be the case for the United Kingdom as a whole and in most health authorities (not only in high prevalence areas). 8 10 Previous work which supports this programme was published last year as recommendations from the royal colleges in medicine, nursing, and midwifery and the Public Health Laboratory Service.11 These emphasised that testing of mothers had to be with verbal consent; arrangements had to be in place to manage promptly and advise women found to be HIV infected; expert advice should be available to those providing care; and ethnic minority groups particularly affected needed to be involved in this process.11 As for all diagnostic HIV testing, clinical and laboratory procedures need to be adhered to, ensuring that when initial tests give positive results they are repeated on a second specimen and that repeat positive results are confirmed by a specialist laboratory.12
An intermediate objective for reducing mother to child transmission is that 80% of HIV positive women giving birth should have their infection diagnosed. This target is already monitored through the unlinked anonymous programmes and national surveillance of pregnant women and children,4 but a study by the group implementing antenatal HIV testing in London has already made it clear that many hospitals' information systems cannot provide data on the proportion of women screened, let alone the proportion offered the test.13
Therefore information systems will urgently need to be developed so that the uptake of HIV tests and other antenatal tests such as those for hepatitis B, syphilis, and rubella can be recorded and performance monitored.8 This is in accordance with other initiatives to improve quality in screening programmes by the National Screening Committee.14
The government's year targets for the year 2000 are entirely
achievable. Some hospitals in London and Edinburgh have shown that when
an offer and recommendation of voluntary HIV testing is made routine as
part of standard antenatal care uptake exceeds 80%.
13 15
Some London hospitals have already seen an increase in the proportion
of HIV infected women detected.4 The challenge that
remains is to extend this to the rest of the UK, to sustain improvements and to use the lessons learnt to benefit all aspects of
screening and care in pregnancy.
HIV and STD Division, PHLS Communicable Disease Surveillance
Centre, London NW9 5EQ Department of Epidemiology and Public Health, Institute of
Child Health, London WC1N 1EH
Angus Nicoll
Catherine Peckham
Footnotes
website extra: A fuller version of the government targets appears on the BMJ's website www.bmj.com
| 1. |
Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G.
O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type-1 with zidovudine treatment.
N Engl Med
1994;
331:
1173-1180 |
| 2. |
Duong T, Ades AE, Gibb DM, Tookey PA, Masters J.
Verical transmission rates for HIV in the British Isles: estimates based on surveillance data.
BMJ
1999;
319:
1227-1229 |
| 3. |
Lindegren M, Byers RH, Thomas P, Davis SF, Caldwell B, Rogers R, et al.
Trends in perinatal transmission of HIV/AIDS in the United States.
JAMA
1999;
282:
531-538 |
| 4. |
Communicable Disease Surveillance Centre, Scottish Centre for Infection and Environmental Health, Institute of Child Health (London), Oxford Haemophilia Centre.
AIDS and HIV-1 Infection in the United Kingdom: monthly report (HIV infection in pregnant women giving birth in the UK levels of infection and proportions diagnosed).
Comm Dis Report
1999;
9:
45-48.
|
| 5. | Nicoll A, Steele R, Mortimer P. Pregnant woman and testing for HIV. Practising Midwife 1999; 2(8): 34-37. |
| 6. |
Gibb DM, MacDonagh S, Gupta R, Tookey PA, Peckham CS, Ades AE, et al.
Factors affecting uptake of antenatal HIV testing in London: results from a multicentre study.
BMJ
1998;
316:
259-261 |
| 7. |
Jones S, Sadler T, Low N, Blott M, Welch M.
Does uptake of antenatal HIV testing depend on the individual midwife? Cross sectional study.
BMJ
1998;
316:
272-273 |
| 8. | Department of Health. Reducing mother to baby transmission of HIV. London: NHS Executive, 1999 (HSC 1999/183). |
| 9. | UK Health Departments. Targets aimed at reducing the number of children born with HIV: report from an expert group. London: Department of Health, 1999. |
| 10. |
Ades AE, Sculpher MJ, Gibb DM, Gupta R, Ratcliffe J.
A cost-effectiveness analysis of antenatal HIV testing in the UK.
BMJ
1999;
319:
1230-1234 |
| 11. | Intercollegiate Working Party for Enhancing Voluntary Confidential HIV Testing in Pregnancy. Reducing mother to child transmission of HIV infection in the UK. London: Royal College of Paediatrics and Child Health, 1998. |
| 12. | PHLS HIV Diagnosis Working Group. Towards error free HIV diagnosis: notes on laboratory practice. PHLS Microbiology Digest 1992; 9: 61-64. |
| 13. | Pan-London antenatal HIV testing implementation group. Review of antenatal HIV testing services in London. London: NHS Regional Office, 1999. |
| 14. | Quality management for screening. London: National Screening Committee, 1999. |
| 15. |
Simpson WM, Johnstone FF, Goldberg DJ, Gormley SM, Hart GJ.
Antenatal HIV testing: assessment of a routine voluntary approach.
BMJ
1999;
318:
1660-1661 |
Read all Rapid Responses